4015 · 22/07/2026 08:02:20 · Announcement #96921 · View on Saudi Exchange

Jamjoom Pharmaceuticals Factory Co. announces its Interim Financial results for the Period Ending on 2026-06-30 ( Six Months )

Element ListCurrent QuarterSimilar quarter for previous year%ChangePrevious Quarter% Change
Sales/Revenue 445.31396.2212.389481.38-7.493
Gross Profit (Loss) 293.65250.817.085310.38-5.39
Operational Profit (Loss) 146135.357.868172.38-15.303
Net Profit (Loss) Attributable to Shareholders of the Issuer 137.63132.024.249168.21-18.179
Total Comprehensive Income Attributable to Shareholders of the Issuer 148.65135.279.891152.84-2.741
All figures are in (Millions) Saudi Arabia, Riyals
Element ListCurrent PeriodSimilar period for previous year%Change
Sales/Revenue 926.7853.758.544
Gross Profit (Loss) 604.03543.6411.108
Operational Profit (Loss) 318.37293.538.462
Net Profit (Loss) Attributable to Shareholders of the Issuer 305.84289.065.805
Total Comprehensive Income Attributable to Shareholders of the Issuer 301.49293.382.764
Total Shareholders Equity (after Deducting Minority Equity) 1,878.251,681.7911.681
Profit (Loss) per Share 4.374.13
All figures are in (Millions) Saudi Arabia, Riyals
Element ListAmountPercentage of the capital (%)
Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value --
Accumulated Losses --
All figures are in (Millions) Saudi Arabia, Riyals
Element ListExplanation
The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is Revenue increased by 12.4% to SAR 445.3 million, driven by higher volumes and a favorable product mix, supported by sustained demand for strategic brands and strong growth in the Gulf, North Africa and other export markets.
The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is Net profit increased by 4.2% to SAR 137.6 million, supported by revenue growth and gross-margin expansion, partly offset by higher operating expenses, lower other income and lower income from joint venture.
The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the previous one is Revenue for the current quarter decreased by 7.5% compared to the first quarter of 2026, as the first quarter is typically stronger in terms of revenue due to higher number of deliveries occurring at the start of the year.
The reason of the increase (decrease) in the net profit (loss) during the current quarter compared to the previous one is Net profit for the current quarter decreased by 18.2% compared to the first quarter of 2026, mainly due to lower revenue and higher selling and distribution expenses resulting from more hiring and promotional activity during the quarter.
The reason of the increase (decrease) in the sales/ revenues during the current period compared to the same period of the last year is Revenue increased by 8.5% to SAR 926.7 million, driven by higher volumes, favorable product mix across strategic brands and sales growth across key markets.
The reason of the increase (decrease) in the net profit during the current period compared to the same period of the last year is Net profit increased by 5.8% to SAR 305.8 million, supported by revenue growth and gross-margin expansion, partly offset by higher operating expenses due to increase in commercial hiring and promotional activity, an adverse foreign-exchange impact compared with a gain in the prior-year period and lower share of profit from the Joint Venture.
Statement of the type of external auditor's report Unmodified conclusion
Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion) None
Reclassification of Comparison Items None
Additional Information Please refer to the attached Earnings Release for more information on the 2Q and H1 2026 results.
Attached Documents  

The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.